Objectives: To test the hypothesis that obesity (increase in fat mass) independently affects the level of adipokines: adiponectin, tumor necrosis factor-a (TNFa) and interleukin (IL)-6. Methods: Publications in the past decade reporting adult plasma adiponectin, leptin, TNFa and/or IL-6 levels were compiled. Mean gender-specific values were extracted from studies that included medical screening to confirm physical health (43 groups, total 4852 subjects). Correlation analysis was conducted between adipokine levels and body mass index (BMI), a widely used estimate of adiposity. Results: For healthy lean to obese adults of both genders, no significant correlation between plasma adiponectin and BMI was detected. There was also no gender difference in plasma adiponectin level. In contrast, leptin levels showed a positive correlation with BMI in both genders, and women had significantly higher levels of plasma leptin consistent with a higher percentage of body fat. The proinflammatory cytokine TNFa failed to show correlation with BMI. Although IL-6 showed a positive correlation with BMI in women, the obesity-related increase was very limited. Conclusions: Data analysis based on studies performed on healthy adults did not support the hypothesis that obesity independently affects the plasma level of adiponectin and TNFa. Reported obesity-related changes in plasma adipokine levels may be a consequence of obesity-related metabolic disorders. Future studies are especially needed to understand the homeostasis of adiponectin.
Introduction
Obesity is a state of increased adipocyte size and subsequently an increase in total fat mass. 1 With the industrialization, obesity is becoming a large health burden because of its association with the risk for disorders such as dyslipidemia, insulin resistance, hypertension, and eventually atherosclerosis and other cardiovascular diseases. [2] [3] [4] [5] [6] [7] Although the risk is well established, the mechanisms leading to the risk are not clear. A change in the plasma adipokine profile in obese individuals, such as the levels of adiponectin and the proinflammatory cytokines, tumor necrosis factor-a (TNFa) and interleukin (IL)-6, was proposed to be a contributing factor. However, in some cases, individuals were classified as obese, but showed no disorders. 8 Transgenic fatless mice, upon excessive weight gain, also developed type 2 diabetes. 9 Examining the homeostasis of adipokines in healthy obese individuals thus is one step toward understanding the health risk of obesity, and this is the long-term aim of our analysis. Adiponectin and leptin are cytokines mainly produced from the white adipose tissue as transgenic fatless mice have little serum leptin and adiponectin. 9 Leptin relayed fat storage size to the central nervous system to regulate food intake and energy storage. 10 Rodents deficient in leptin or leptin receptor developed severe obesity and obesity-associated pathological conditions due to a disrupted communication between peripheral tissue and central nervous system. 11, 12 On the basis of the source and biological function of leptin, it was expected and indeed well established that the circulating level of leptin increases proportional to the degree of obesity. 10 Circulating level of adiponectin is 100-to 1000-fold than that of leptin. 10 In contrast to leptin knockout mice, adiponectin knockout mice fed regular chow were quite normal. 13, 14 Under high-fat diet, knockout mice exhibited metabolic disturbance including elevated plasma free fatty acid levels and insulin resistance. However, the metabolic disturbance was independent of body weight as the body weight of adiponectin knockout mice was similar to that of the wild-type mice fed the same diet (regular or high-fat diet).
13,14
These observations do not support a role of adiponectin in body weight regulation, which is different from leptin. Instead, adiponectin seems to be important for energy metabolism, especially the metabolism of free fatty acids. Epidemiological studies reported an association of lower plasma adiponectin levels with metabolic syndrome, type 2 diabetes 15,16 and cardiovascular diseases. 17 As the risk for these disorders increases with obesity, several types of studies tested the hypothesis that obesity depresses the plasma adiponectin level, which in turn increases the risk for diabetes and cardiovascular diseases. Weight reduction through gastric surgery 18 or the removal of visceral fat 19 led to the amelioration of insulin resistance and an increase in plasma adiponectin. However, plasma levels of adiponectin were shown to be more closely related to insulin resistance 20, 21 or type 2 diabetes 22 than with adiposity. In fact, for healthy human subjects and animal, moderate weight loss did not necessarily translate to changes in the plasma adiponectin level. 23, 24 For subjects with metabolic abnormalities, weight loss larger than 10% was needed to change plasma adiponectin levels. 25 Also, patients with defective growth hormone receptor showed elevated plasma adiponectin despite marked obesity. 26 Limitations such as interventions applied, small sample size and disease conditions (or unclear health status) were often observed in other human studies and thus compromised the ability to conclude that obesity directly suppresses the plasma adiponectin level.
To examine whether obesity independently depresses the plasma level of adiponectin, we performed pooled data analysis using published studies on clinically evaluated nonintervened healthy subjects. Body mass index (BMI) was used to quantify the degree of obesity. Partly because of the easiness in obtaining the information, BMI values were available in almost all literatures that examined adiposity. BMI was also shown to be as effective as other anthropometric variables in estimating adiposity-related outcome based on the National Health and Nutrition Examination Survey III data analysis. 27 We limited the analysis to those studies providing gender-specific data because women are known to have higher percentage body fat than men at the same BMI. [28] [29] [30] To validate the quality of our analyses, plasma leptin level, which was known to increase with obesity and found to be higher in women, 31 was also analyzed here as a positive control. The same BMI correlation analyses were also applied to two proinflammatory cytokines, IL-6 and TNFa. They are mainly from macrophages, but also secreted by adipocytes. 32 Obesity is considered a low-grade inflammatory state 33 and proinflammatory cytokines were thought to be involved in the development of obesity-related insulin resistance and cardiovascular diseases. However, not all studies found a correlation between plasma proinflammatory cytokine levels and obesity. 34 Similar to adiponectin, the secretion of proinflammatory cytokines was known to be affected by diabetes 35, 36 and cardiovascular diseases. [37] [38] [39] In addition, their levels rose on infection, inflammation or acute stress. 40 To determine the independent effect of obesity on their levels, our analysis was again restricted to data from studies that enrolled clinically evaluated non-intervened healthy subjects. excluded are a few studies reporting values of leptin or adiponectin that are at least 10-fold different, higher or lower, from the mean of other publications. Of the remaining studies, because of the known continuous body composition changes from birth to adulthood (18 years old), 44 only studies on subjects older than 18 years of age were included in the analysis. Furthermore, studies reporting mean values combining observations from both genders were not used because of the known gender difference in percentage body fat, [28] [29] [30] fat distribution 29 and plasma leptin level. 31 Overall, the three exclusion criteria, concerns on subject health, young age and a lack of gender focus, led to the majority of the data exclusion. Male data were compiled from 13 studies (17 groups of individuals), with group sample size ranging from 10 to 466 individuals and a mean group sample size of 142. 29, 34, [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] Female data were compiled from 15 studies (26 groups of individuals), with study sample size ranging from 8 to 662 individuals and a mean sample size of 94. 29, 45, 46, 48, 50, [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] Lack of BMI-adiponectin association S-M Kuo and MM Halpern Among these studies, eight studies included subjects of both genders and the measurements from men and women were reported separately. The sample size as well as the age and BMI profiles of these studies are summarized in Table 1 .
Materials and methods

Data collection
Data analysis
Mean values of adipokines and BMI in each study were used for the linear regression analysis and the computation of Pearson's correlation coefficient. Significant correlation was defined as Po0.05. In three studies, experimental results were reported as means and data ranges instead of means and standard deviations. 45, 48, 55 For the purpose of data plotting, we calculated standard deviations for those studies by dividing the difference between the reported maximum and minimum values by 4. This estimation did not impact on the correlation analysis. Gender difference was determined by two-tailed Student's t-test and significant difference was defined as Po0.05.
Results
Profile of studies included in the analysis Table 1 In the following data analysis, mean BMI was used as the independent variable to represent the degree of obesity of the subject group. The linear relationship between each dependent variable, mean plasma adiponectin, leptin, IL-6 or TNFa, with mean BMI, was analyzed to see if BMI can predict the plasma level of these adipokines. In addition, we used Student's t-test to examine whether there was gender difference in mean plasma levels of adiponectin, leptin, IL-6 or TNFa.
Analyses of adiponectin and leptin
Linear regression of plasma adiponectin against BMI was performed separately for men ( Figure 1a ) and women ( Figure 1b Lack of BMI-adiponectin association S-M Kuo and MM Halpern cular weight) to high-molecular weight 16-18mers. 63, 64 Because adiponectin levels were determined by enzymelinked immunosorbent assay or radioimmunoassay, which by nature could not distinguish different structural forms, the BMI-adiponectin regression analysis was based on the total adiponectin. Specialized enzyme-linked immunosorbent assay that only measured high-molecular weight adiponectin was used in one male study. 52 Removing the high-molecular weight data point from the regression analysis did not affect the conclusion of no BMI-adiponectin correlation.
The results of plasma leptin to BMI regression analysis are shown in Figure 2 . The regression analysis of male leptin to BMI was based on data from 10 groups (Figure 2a ) 45 The plasma level of leptin was shown to be significantly higher in women compared with men. 31 This gender difference in plasma leptin level was also significant in our data analysis (mean ± s.d., 7.75 ± 7.13 vs 22.5 ± 12.2 ng ml À1 , M vs F). In contrast, the plasma level of adiponectin was not significantly different between men and women in our data analysis (mean ± s.d., 7.34 ± 2.74 vs 9.31 ± 4.81 mg ml
À1
, M vs F).
On the basis of the positive correlation between plasma leptin and BMI ( Figure 2 ) and no correlation between adiponectin and BMI (Figure 1) , we expected no correlation between plasma adiponectin and leptin in healthy individuals. Some studies we compiled reported both plasma leptin and adiponectin measurements, thus allowing the correlation analysis between adiponectin and leptin. The regression analysis of male adiponectin to leptin was performed on data from seven groups 45,47,49,50,53,54 and Pearson's correlation was 0.53 (P40.05, not significant).
The regression analysis of female adiponectin to leptin was based on data from 13 groups 45,50,53,54,56,58,61,62 and Pearson's correlation was 0.37 (P40.05, not significant). The analysis confirmed the expected lack of correlation between adiponectin and leptin in healthy individuals.
Analyses of TNFa and IL-6
The plasma TNFa and IL-6 data that we compiled are shown in Figures 3a and 4a (men) and Figures 3b and 4b (women) . After applying our data exclusion criteria, we found very limited information available on the plasma TNFa level of healthy adult men (Figure 3a) , 29 ,55 so regression analysis was not possible. The regression analysis of female TNFa to BMI was based on data from 12 groups (Figure 3b ) 29, 55, [57] [58] [59] [60] and Pearson's correlation was 0.51 (P40.05, not significant).
There was also limited information available (six groups) on the plasma IL-6 level of healthy adult men (Figure 4a) . 29 Table 1 . Some error bars are too small to be visible. Table 1 . Some error bars are too small to be visible.
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( Figure 4b) . 29, 45, 46, 55, 57, 59 The Pearson's correlation was 0.85 (Po0.05), indicating a significant positive correlation between plasma IL-6 and BMI in healthy adult women. No gender differences were found in plasma levels of TNFa and IL-6. The plasma level of TNFa in healthy adult women was 3.55 ± 2.72 pg ml À1 (mean ± s.d.), which was similar to the mean plasma level of TNFa from two healthy adult male groups (2.90 pg ml
À1
). The plasma levels of IL-6 in healthy adult men and women were 1.20 ± 0.21 and 1.51±0.48 pg ml
, respectively (mean±s.d.).
Discussion
We conducted pooled data analysis on healthy subjects to determine whether obesity, in the absence of metabolic disorders, independently affected the plasma level of adipokines. Although plasma leptin level, our positive control, showed a positive correlation with BMI (Figure 2) , we did not find a correlation between BMI and plasma levels of adiponectin or TNFa in the same population of healthy normal to obese adults (Figures 1 and 3) . Although a positive correlation was found between BMI and IL-6 in women (Figure 4b ), the magnitude of changes was limited. Women are known to have higher body fat content than men and, as expected, the positive control leptin showed significantly higher levels in women than men (Figure 2 ). In contrast, the levels of adiponectin, TNFa and IL-6 did not exhibit gender differences, which was consistent with their lack of correlation with adiposity. Gender-specific pooled data analysis of adipokines in healthy adults has never been reported before. Our finding on the lack of correlation between BMI and adiponectin level in healthy adults strengthened a similar conclusion drawn from subjects with various degrees of insulin resistance. 20, 65 Although adiponectin is known to have different structural complexes, low-molecular weight, medium molecular weight and highmolecular weight, 63, 64 total adiponectin was reported in almost all studies so that the effect of BMI on the distribution of adiponectin complexes cannot be determined. The distribution of three complexes is known to be affected by gender and by insulin resistance. 64 A recent study on women with polycystic ovary syndrome found that the levels of three adiponectin complexes changed largely in parallel to each other. 66 Our findings on adiponectin support the presence of tight regulation of this adipokine. Adiponectin resistance has been observed. 67 In fact, high fat-fed rats developed skeletal muscle adiponectin resistance before the onset of insulin resistance. 67 Also, transgenic adiponectin-overexpressing mice eventually had lower circulating adiponectin level than that of wild-type mice indicating the presence of feedback regulation. 68 It is known that changes in gene expression cannot always explain the changes in circulating adiponectin levels. 69 Thus, a simple expansion of adipose tissue in healthy obese individuals should not be expected to affect the plasma level of adiponectin and the results of our analysis supported this ( Figure 1 ). Instead, regulation at the rate of adiponectin secretion may happen under various obesity-related pathological conditions such as the metabolic syndrome, 70 which then lead to a lower plasma adiponectin levels. [15] [16] [17] 71 Metabolic syndrome, because of its association with the infiltration of macrophages, is considered a state of tissue inflammation. 71 Conditions found in the metabolic syndrome such as high plasma glucose, 72 high dietary fat, 73 changes in very-low-density lipoprotein metabolism 74 and inflammatory cytokines 70, 75 are all known to inhibit adiponectin secretion in vitro.
Our analysis cannot provide direct information on the biochemicals involved in the physiological regulation of adiponectin secretion. However, the results of our analysis were consistent with a role of free fatty acids, specifically an elevation of circulating free fatty acids led to the decrease in the circulating level of adiponectin. Although plasma free fatty acid levels were not always measured in human studies, elevated levels of free fatty acid were found in many obesityrelated pathological conditions including type 2 diabetes 76, 77 and metabolic syndrome. 78 Physiological changes due to an elevation in plasma free fatty acids are known and lipotoxicity could be a link between obesity and type 2 diabetes. 79, 80 An elevation of plasma free fatty acids is known in experimental low-dose endotoxemia, a human non-obese model to study inflammatory response. 81 It is possible that some obese individuals remained healthy because of a higher capacity to hold storage fat due to genetic and/or environmental factors. 80 Thus, their fatty acid levels did not increase and adiponectin levels did not decrease. Female subjects in our analysis were able to stay healthy at a higher BMI than male subjects (Figures 1-4) . This may be due to their higher capacity for adipose tissue expansion, likely a gender-specific evolutionary advantage for reproductive success. It is interesting that some other pathological conditions were associated with an elevation of circulating adiponectin. 69 At least one of the conditions, anorexia nervosa, is known to lead to abnormal lipid metabolism.
82 Figure 4 Relationship between baseline plasma IL-6 and BMI in healthy adult men (a) and women (b). Mean and standard deviation of plasma IL-6 and the corresponding mean BMI were compiled from various male 29, 34, 45, 46 and female 29, 45, 46, 55, 57, 59 studies included in Table 1 . Some error bars are too small to be visible. Po0.01 for the correlation between plasma IL-6 and BMI in women.
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Future human studies correlating the plasma level of free fatty acids (and perhaps even the type of free fatty acids 83, 84 ) and that of adiponectin are needed to further examine the potential free fatty acid-adiponectin link. Results from correlation studies performed on healthy human studies suggest that such a link exist. 85, 86 Although acute druginduced reduction of plasma free fatty acid in healthy human subjects was associated with a reduction of plasma adiponectin, 87 niacin treatment that decreased plasma free fatty acids led to a rapid increase in the plasma adiponectin concentration in healthy rats and mice likely through an increased secretion. 88 Studies on animal models provided additional information on the link between adiponectin and free fatty acids. Adiponectin appeared to be important for the metabolism of fatty acids as shown in mouse models. 13, 14, 89 The absence of adiponectin coincided with a higher plasma free fatty acid level. 13 Adiponectin treatment dose-dependently decreased plasma free fatty acid levels. 89 Rats given high-fat diet, which is known to increase the plasma level of free fatty acids, 13, 79 developed skeletal muscle adiponectin resistance before insulin resistance 67 and the resistance could not be explained by muscle inflammation. 83 Our analysis revealed a significant correlation between BMI and plasma IL-6 (Figure 4b ), but not between BMI and plasma TNFa (Figure 3b ). This is consistent with the in vitro observation on adipocytes where larger adipocytes were shown to release more IL-6, but not more TNFa. 90 However, the physiological significance of the positive correlation between BMI and IL-6 is not clear. IL-6 is estimated to increase from about 1 pg ml À1 at BMI of 22 mg kg À2 to about 2.5 pg ml À1 at BMI of 37 mg kg À2 (a state of severe obesity) (Figure 4b ). This increase was very limited in amount compared with the IL-6 level of post-cardiac disease, 91 post-coronary artery bypass surgery patients 92 or experimental low-dose entotoxemia in healthy human subjects. 81 It is not convincing that the slight IL-6 elevation can contribute to the development of obesity-related metabolic diseases. Several recent reviews also reached the same conclusion. [93] [94] [95] In summary, our gender-specific analysis on healthy adults did not support an association between adiposity and plasma adiponectin level despite a significant positive correlation between adiposity and leptin, another white adipose tissue cytokine. A constant plasma adiponectin level in healthy normal to obese subjects suggested the presence of regulatory mechanisms. Because of the known biological importance of adiponectin and an observed decrease of adiponectin level in metabolic diseases, [15] [16] [17] 71 understanding the regulatory mechanisms for adiponectin would help the management of metabolic diseases.
Conflict of interest
The authors declare no conflict of interest.
